Human papillomavirus (HPV) vaccines

Loading...
Thumbnail Image

Authors

Visser, Adele
Hoosen, Anwar Ahmed

Journal Title

Journal ISSN

Volume Title

Publisher

Health and Medical Publishing Group

Abstract

Human papillomavirus (HPV) infection has been estimated to cause 270 000 deaths worldwide annually from cervical cancer and approximately 80% of these occur in resource-poor countries. In South Africa, cervical cancer is the second most common malignancy among women, with the highest rate among black women aged 66 - 69 years. With the development of prophylactic HPV vaccines there are prospects of significant reduction in morbidity and mortality due to HPV infection and its complications.

Description

Keywords

Human papillomavirus vaccine

Sustainable Development Goals

Citation

Visser, A & Hoosen, A 2012, 'Human papillomavirus (HPV) vaccines', CME : Continuing Medical Education, vol. 30, no. 1, pp. 29.